Company intelligence / Profile preview
Farmayala Pharmaceutical Company S.A.
- Ownership
- Private
- Development stage
- Commercial
Overview
Farmayala Pharmaceutical Company S.A. develops, manufactures, imports/exports, and markets a broad range of prescription drugs including antivirals, mucolytics, analgesics/muscle relaxants, among others. The company operates primarily in Ecuador with commercial presence across several cities. No clinical trial or pipeline-stage drug development was identified; the focus appears to be on generic or branded-generic pharmaceuticals for established indications.
No recent clinical results were found—company appears to operate at the commercial stage.- Therapeutic areas
- PulmonologyOtherRheumatologyGastroenterologyNeurologyInfectious Diseases
- Modalities
- Small molecules
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Farmayala Pharmaceutical Company S.A..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Farmayala Pharmaceutical Company S.A..